If You Invested $10K In Omega Healthcare Investors Stock 10 Years Ago, How Much Would You Have Now?
Omega Healthcare Investors Inc. (NYSE:OHI) is a real estate investment trust that primarily invests in skilled nursing and assisted living facilities in the U.S. and the U.K.
It is set to report its Q2 2025 earnings on July 31. Wall Street analysts expect the company to post EPS of $0.75, up from $0.71 in the prior-year period. According to Benzinga Pro, quarterly revenue is expected to reach $295.80 million, up from $252.75 million a year earlier.
Don't Miss:
Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. .
Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales —
The company's stock traded at approximately $34.79 per share 10 years ago. If you had invested $10,000, you could have bought roughly 287 shares. Currently, shares trade at $36.67, meaning your investment's value could have grown to $10,540 from stock price appreciation alone. However, Omega Healthcare also paid dividends during these 10 years.
Omega Healthcare's dividend yield is currently 7.31%. Over the last 10 years, it has paid about $27.11 in dividends per share, which means you could have made $7,792 from dividends alone.
Summing up $10,540 and $7,792, we end up with the final value of your investment, which is $18,332. This is how much you could have made if you had invested $10,000 in Omega Healthcare stock 10 years ago. This means a total return of 83.32%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 256.40%.
Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs —
Omega Healthcare has a consensus rating of "Buy" and a price target of $36.28 based on the ratings of 20 analysts. The price target implies around 1% potential downside from the current stock price.
The company on May 1 announced its Q1 2025 earnings, posting FFO of $0.75, beating the consensus estimate of $0.74, while revenues of $276.80 million came in below the consensus of $288.69 million, as reported by Benzinga.
"We are pleased with our first quarter results, as we continue to grow FAD per share, while further de-levering the balance sheet. We have accretively invested approximately $423 million year-to-date through April 30th and, as a result, we are increasing our 2025 AFFO guidance to be between $2.95 and $3.01 per share from our previous guidance of between $2.90 and $2.98 per share," said CEO Taylor Pickett.
Check out this article by Benzinga for four analysts' insights on Omega Healthcare.
Given no expected upside potential, growth-focused investors may not find Omega Healthcare stock attractive. Conversely, the stock can be a good option for income-focused investors, who can benefit from the company's solid dividend yield of 7.31%.
Read Next:
Maximize saving for your retirement and cut down on taxes: .
, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum.
Image: Shutterstock
This article If You Invested $10K In Omega Healthcare Investors Stock 10 Years Ago, How Much Would You Have Now? originally appeared on Benzinga.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gizmodo
17 minutes ago
- Gizmodo
OpenAI Hits Pause on Its Meta Killer
OpenAI is delaying the release of its much-anticipated open-weight AI model, citing the need for 'additional safety tests' and last-minute concerns over 'high-risk areas,' CEO Sam Altman announced on X (formerly Twitter). The decision lands in the middle of a brutal AI arms race, particularly with Meta, which has been aggressively poaching OpenAI talent and championing open-source models like Llama 3. The model, which was slated to drop this week, would be OpenAI's first major open-weight system, meaning developers would be free to download and use the model's underlying code and data weights to build their own apps, research projects, or commercial tools. But as Altman pointed out, once these models are released, 'they can't be pulled back.' That's the nature of open-source, and it's exactly why this delay is raising eyebrows across the AI community. 'While we trust the community will build great things with this model, once weights are out, they can't be pulled back,' Altman wrote on X (formerly Twitter) on July 11. 'This is new for us and we want to get it right.' we planned to launch our open-weight model next week. we are delaying it; we need time to run additional safety tests and review high-risk areas. we are not yet sure how long it will take us. while we trust the community will build great things with this model, once weights are… — Sam Altman (@sama) July 12, 2025In AI, 'weights' are the millions of numerical values that act like the model's brain wiring, allowing it to make connections and decisions. When a company releases a model as 'open-weight,' it's not just sharing a blueprint; it's giving away the fully functional brain. Developers are free to download it, modify it, and use it for everything from building chatbots and productivity tools to creating deepfakes and other malicious applications. Open-sourcing models accelerates innovation, but it also raises the risk of misuse, misinformation, and untraceable custom versions. That's why the decision to delay, while frustrating to many, signals that OpenAI is trying to tread cautiously, especially as criticism around AI safety and 'model leaking' intensifies. According to developer chatter online, the delay may have been triggered by a major technical issue discovered just before launch. The rumored model was expected to be smaller than Kimi K2—the new open-weight model from Chinese AI startup Moonshot AI that reportedly clocks in at nearly a trillion parameters—but still 'super powerful,' according to early testers. Kimi K2, which is taking on ChatGPT with impressive coding capabilities at a lower price, was released on July 11, the same day as Altman's announcement. While some online speculators blamed the delay on Kimi's unexpectedly strong performance and a fear of being outshone, there's no confirmation of that from OpenAI. What is clear is that the company is feeling the pressure to deliver something that is safe, fast, and competitive. Rumors that OpenAI delayed their open-source model because of Kimi are fun, but from what I hear: – the model is much smaller than Kimi K2 (<< 1T parameters)– super powerful– but due to some (frankly absurd) reason I can't say, they realized a big issue just before release, so… — Yuchen Jin (@Yuchenj_UW) July 13, 2025OpenAI's delay comes at a time when Meta is eating its lunch, at least in the open-source department. Mark Zuckerberg's company has released increasingly powerful open-weight models like Llama 3, all while quietly hiring away top OpenAI researchers. The talent war is real, and it's affecting timelines and strategy across the board. By delaying this release, OpenAI may be hoping to avoid a flawed launch that could dent its credibility at a critical moment. But it also risks falling further behind Meta, which has already become the go-to platform for developers looking to build with transparent, modifiable AI tools. OpenAI hasn't offered a new timeline for the release. That silence is fueling speculation that the delay could last weeks. If retraining is truly on the table, it could push the launch closer to the fall. For now, the open-source community is in wait-and-see mode. And the question hanging over it all: Can OpenAI deliver a model that is powerful, safe, and competitive enough to match Meta's momentum and keep the Chinese rivals at bay? In other words, can they get it right before someone else does?
Wall Street Journal
18 minutes ago
- Wall Street Journal
Kneecap and Other Nonsense of the Day
At a certain age you realize there's only so much new nonsense you can take on board. This memory-almost-full realization is at odds with the culture's drive to shovel new nonsense in your direction. The modern digital economy assumes that you have an unlimited appetite for diversions. The algorithm is relentless. To get by without getting bogged down, it's necessary to cultivate habits of discernment. The Book of Proverbs teaches that fear of the Lord is the beginning of wisdom. In 2025 fear of distraction can't be far behind. Mindfulness is the rage. Highly successful people work hard at keeping the background noise of life to a minimum. CEOs are careful to avoid unnecessary meetings and frivolous conversations. The goals is to open up space for the kinds of surprises that come only when the mind—and the calendar—is clear. But discernment is more than developing the ability to maintain focus or opening yourself to inspiration. It's learning the difference between what matters and what doesn't. Most of us don't develop this ability without taking a few of life's lumps. Losing someone you care about answers more of the fundamental questions than any college philosophy class. Having kids does the same thing. After you become a parent, the nonsense that once concerned you simply doesn't anymore, while things you never much cared about become your obsession. Mortgage rates, for instance. Or the abysmal state of public education.
Bloomberg
19 minutes ago
- Bloomberg
JPMorgan Forms New Banking Team Focused on Bespoke Financings
JPMorgan Chase & Co. created a unit in its commercial and investment bank focused on bespoke financing structures across public and private markets. The business, dubbed strategic financing solutions, will be a collaboration between banking, markets and sales, according to an internal memo Monday. It will initially focus on structured private solutions, infrastructure finance, strategic asset-backed securities finance, merchant banking and direct lending.
